Feb 25, 2026 09:01AM Trinity Biotech secures $25 million financing agreement with Yorkville

Feb 20, 2026 05:01PM Trinity Biotech receives Nasdaq non-compliance notice for share value

Feb 20, 2026 05:01PM Trinity Biotech receives nasdaq non-compliance notice for market value

Feb 10, 2026 01:29PM Trinity Biotech receives approval to start outsourced HIV test manufacturing

Feb 10, 2026 08:00AM Trinity Biotech wins IFCC gold classification for diabetes analyzer

Dec 23, 2025 08:50AM Trinity Biotech secures funding agreements with Perceptive Advisors

Dec 23, 2025 07:32AM Trinity Biotech receives order for 9 million HIV tests

Dec 15, 2025 09:15AM Trinity Biotech expands HbA1c column system rollout to 10+ countries

Nov 18, 2025 09:00AM Trinity Biotech receives WHO approval for outsourced HIV test manufacturing

Aug 21, 2025 09:02AM Trinity Biotech appoints Paul Tivnan as non-executive director

Aug 20, 2025 09:03AM Trinity Biotech receives approval to offshore HIV test manufacturing

Aug 14, 2025 09:00AM Trinity Biotech gets approval to offer preeclampsia test in New York

Aug 7, 2025 08:01AM Trinity Biotech launches FDA-cleared preeclampsia test service

Jul 24, 2025 08:21AM Trinity Biotech unveils CGM+ wearable biosensor for AI health market

Jul 22, 2025 09:27AM MHRA on Trinity Biotech (TRIB) Premier Hb9210: Risk of Positive Bias and Updates to Instructions for Use (IFU), including use as a diagnostic aid in diabetes mellitus

Jun 24, 2025 08:01AM Trinity Biotech (TRIB) Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

Feb 28, 2025 08:31AM Trinity Biotech (TRIB) Announces Additional Funding

Feb 6, 2025 07:32AM Trinity Biotech (TRIB) Reports First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Jan 28, 2025 07:21AM Trinity Biotech (TRIB) Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Dec 18, 2024 11:01AM Trinity Biotech (TRIB) Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Nov 7, 2024 08:21AM Trinity Biotech (TRIB) Regains Nasdaq Compliance

Oct 25, 2024 08:45AM Trinity Biotech (TRIB) Announces Strategic Investment in Novus Diagnostics

Oct 25, 2024 08:45AM Trinity Biotech (TRIB) Acquires EpiCapture

Oct 7, 2024 08:15AM Trinity Biotech (TRIB) Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Sep 24, 2024 04:05PM Trinity Biotech (TRIB) Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 18, 2024 04:06PM Trinity Biotech (TRIB) to Initiate CGM Market Study in India

Sep 3, 2024 09:55AM Trinity Biotech (TRIB) Appoints Adrian Donohue as Chief Commercial Officer

Aug 26, 2024 04:05PM Trinity Biotech (TRIB) Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Aug 20, 2024 05:00PM Trinity Biotech (TRIB) Appoints David Ouston as Biosensor Marketing Director

Aug 6, 2024 04:07PM Trinity Biotech (TRIB) Receives Extension to Regain Nasdaq Compliance

Aug 2, 2024 09:25AM Trinity Biotech (TRIB) Reports Prelim Q2 Revenues of $15.5M-$16M, Enters UK Distribution Agreement with MedScience

Jul 9, 2024 04:06PM Trinity Biotech (TRIB) Appoints Louise Tallon as CFO